Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus).
Monkey B virus (Macacine herpesvirus 1; BV) is endemic in macaques. BV (a BSL4 agent) is the primary zoonotic concern for persons working with macaques in research, and human BV infections frequently are fatal. We assessed the use of a BSL2 baboon herpesvirus (Papiine herpesvirus 1; HVP2) for predicting the drug sensitivity of BV by comparing the sensitivity of the 2 viruses to 12 antiherpetic drugs. Plaque reduction assays showed that 4 drugs (HBPG, BVdU, PFA, and BrdU) were ineffective against both viruses. Of the 8 effective drugs, both viruses were most sensitive to TFT, whereas sensitivity to the remaining 7 drugs varied between BV and HVP2 as well as between strains of HVP2. In addition, the efficacy of 5 drugs (ACV, PCV, GCV, CDV, and EDU) was tested by using a murine model. ACV and EDU were completely ineffective against both HVP2 and BV, and high doses of PCV only delayed death by a few days. GCV and CDV both protected mice against death, and CDV also prevented the development of neurologic symptoms. When the initiation of drug therapy was delayed until after virus gained access to the CNS, both GCV and CDV were ineffective. The similarity of the drug sensitivities of HVP2 and BV in both models validates the use of HVP2 as a BSL2 level model that can be used to predict drug sensitivity of BV. The greater efficacy of CDV relative to GCV suggests the potential for use of CDV in the treatment of zoonotic BV infections.
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA.
Lauren A
LA
Brush
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA.
Darla H
DH
Black
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA.
Kimberly A
KA
Mccormack
Department of Physiological Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma, USA.
Lara K
LK
Maxwell
Department of GLSynthesis, Worcester, Massachusetts, USA.
George
G
Wright
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA.
Jerry W
JW
Ritchey
Department of Department of Statistics, Oklahoma State University, Stillwater, Oklahoma, USA.
Mark E
ME
Payton
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA. r.eberle@okstate.edu.
Richard
R
Eberle
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002522:Chlorocebus aethiops; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives; D004195:Disease Models, Animal; D015774:Ganciclovir; D006566:Herpesviridae Infections; D006568:Herpesvirus 1, Cercopithecine; D008253:Macaca mulatta / Q000821:virology*; D051379:Mice; D063065:Organophosphonates; D018139:Simplexvirus / Q000187:drug effects*; D014271:Trifluridine; D014709:Vero Cells; D010948:Viral Plaque Assay
D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir; D014271:Trifluridine